The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.
about
Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseCisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial.An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patientsPredictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy.UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.Current and future biomarkers in the treatment of colorectal cancer.Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.Advances and challenges in hereditary cancer pharmacogenetics.A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.Germline genetic variants with implications for disease risk and therapeutic outcomes.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
P2860
Q28068930-DCA353BE-0E7C-4252-8EA4-AB366D5CFB74Q33427471-756FAB5D-3C46-4E5E-8184-F2EF637D8894Q35603648-09E69F87-669D-4206-A091-2493151D3679Q36815039-11EB9ACA-FF62-4877-97D3-8FCA8CDFED1AQ37682812-BD144A56-CDF7-4593-8C51-034ACBDB8BC8Q37726433-2A772689-1515-4191-AE21-FAFA2A4C7775Q38393997-16057F7D-89ED-4DF8-A876-CE8477CA479EQ38787244-D0107B22-321A-46DE-A3B8-4CDFAFEA7B39Q38922471-1C2DAD0A-C1CA-4CDD-80A9-049AF4C98B09Q38948499-33EC1380-CB0D-4025-88B0-0737E508A546Q40000464-43E3984B-DCBD-46AB-8938-BFB702F31942Q40725730-D130BF3D-9AEB-42EC-9D33-64300E51C0F9Q48100807-F4D11446-E952-4073-855F-65DFE81B53E4Q52362144-C3B39F98-F316-427C-8F42-0D62E61F4E82Q55497899-5E162B6E-576F-4197-A2B9-B3BB594791CC
P2860
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The effect of the UGT1A1*28 al ...... a collaborative meta-analysis.
@en
type
label
The effect of the UGT1A1*28 al ...... a collaborative meta-analysis.
@en
prefLabel
The effect of the UGT1A1*28 al ...... a collaborative meta-analysis.
@en
P2093
P2860
P50
P356
P1476
The effect of the UGT1A1*28 al ...... a collaborative meta-analysis.
@en
P2093
B Glimelius
C J A Punt
D M Kweekel
M W Redman
P2860
P2888
P304
P356
10.1038/TPJ.2014.16
P50
P577
2014-04-08T00:00:00Z
P5875
P6179
1017195614